Equity Research Medical Care Facilities

Should You Buy Concord Medical Services Holdings Limited Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Concord Medical Services Holdings Limited (CCM) carries a solid Quality of Company rating of 6.0/10. Trading at $3.97, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 1 of 1 CirclFi valuation models project upside for Concord Medical Services Holdings Limited (CCM) at $3.97 — the model consensus leans bullish, with a Quality Score of 6.0/10 and Value-Trap risk of 13/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 6.0/10 — Moderate — mixed signals
  • Value Trap Risk: 13/100 — Minimal — healthy fundamentals
  • Fair Value Range: $14.43 – $14.43 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

6.0 /10

Moderate — mixed signals

Value Trap Risk

13 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

1 /13
Active Models

Avg. confidence: 28%

What Is the Investment Case for Concord Medical Services Holdings Limited (CCM) in 2026?

What Is the Bull Case vs the Bear Case for Concord Medical Services Holdings Limited (CCM)?

Bull case versus bear case for Concord Medical Services Holdings Limited (CCM) at $3.97, derived from 1 active CirclFi valuation models on 2026-09-15.
Bull case — $14.43 target (+263.6%) Bear case
According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +263.6% across 1 bullish models from the current price of $3.97. No active model flags significant downside for CCM. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $14.43 (+263.6%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does CCM Compare to Its Medical Care Facilities Peers?

AIRS AirSculpt Technologi
6.1
SYRA Syra Health Corp.
5.9
MCTA Charming Medical Lim
6.1
AGL agilon health, inc.
5.9
RHEP Regional Health Prop
6.2
GBCS Selectis Health, Inc
5.9
PIII P3 Health Partners I
4.7
NUTX Nutex Health Inc.
8.4

Valuation data pages: AIRS · SYRA · MCTA · AGL · RHEP · GBCS · PIII · NUTX · JYNT · ADUS · NHC

See full Medical Care Facilities rankings →

Which Other Stocks Score Like CCM on Quality?

Closest companies to CCM’s Quality of Company score of 6.0/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on CCM?

Spread

0%

Fair Value Range

$14.43 – $14.43

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

PWERM

$14.43 (+263.6%)

Most Bearish

PWERM

$14.43 (+263.6%)

What Are the Biggest Risks of Buying CCM Stock?

Macro/Sector Risk

Medical Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CCM Data Page →

So Is Concord Medical Services Holdings Limited (CCM) Worth Buying in 2026?

Concord Medical Services Holdings Limited at $3.97 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 6.0/10, and the median fair value of $14.43 implies +263.6% return potential. Investors should verify this thesis against their own risk parameters and time horizon.

These are quantitative model outputs, not investment recommendations. Concord Medical Services Holdings Limited's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About CCM Stock?

Should I buy CCM stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for CCM at $3.97. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.0/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Concord Medical Services Holdings Limited?

Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.

How does CCM compare to its competitors?

Among Medical Care Facilities peers, CCM holds a Quality Score of 6.0/10. Comparable companies include AIRS (QOC 6.1), SYRA (QOC 5.9), MCTA (QOC 6.1). The relative ranking helps investors identify whether CCM offers better fundamental quality than alternatives in the same sector.

Is CCM a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CCM's Quality Score of 6.0/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy CCM at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $14.43 to $14.43. At $3.97, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CCM.

View CCM Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →